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Universal health coverage and healthy lives for all are now widely shared goals and
central to the 2030 Agenda for Sustainable Development. Despite signiﬁcant pro-
gress over the last decades, the world is still far from reaching these goals. Billions of
people lack basic coverage of health services, live with unnecessary pain and dis-
ability, or have their lives cut short by avoidable or treatable conditions (Jamison
et al., 2013; Murray et al., 2015; World Health Organization, World Bank, 2015).
At the same time, millions are pushed into poverty simply because they need to use
health services and must pay for them out-of-pocket. Fundamental to this situation
is the way health interventions and the health system are ﬁnanced. Numerous
countries spend less than is required to ensure even themost essential health services,
scarce funds are wasted, out-of-pocket payments remain high and disadvantaged
groups get the least public resources despite having the greatest needs.
It is clear that today’s global and national arrangements for health ﬁnancing
need to change, and this is a multifaceted endeavour. It is about domestic
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ﬁnancing of health systems, joint ﬁnancing of global public goods and
external ﬁnancing of health systems. It is about resource mobilisation, pooling and
effective use. And it is about economics, politics, public health, human rights, law
and ethics. To get health ﬁnancing right, these areas, functions and perspectives
must all be integrated and aligned.
Chatham House Working Group
The need for a broad and fresh look at global health ﬁnancing was the starting
premise for the Chatham House Centre on Global Health Security Working Group
onHealth Financing. TheGroupwas established in 2011, following a conference at
the Centre marking the 10th anniversary of the Commission on Macroeconomics
and Health (Commission on Macroeconomics and Health, 2001). The mandate
was to revisit the central themes addressed by the Commission and develop updated
recommendations in light of new knowledge and developments since 2001. The
Working Group would also build on the insights of three other landmark reports:
the World Development Report 1993 Investing in Health (World Bank, 1993), the
2009 ﬁnal report of the Taskforce on Innovative International Financing for Health
Systems (HLTF, 2009), and the 2010 World Health Report Health Systems
Financing: The Path to Universal Coverage (World Health Organization, 2010).
To facilitate a broad view on health ﬁnancing, the Working Group brought
together members with diverse backgrounds and perspectives from 15 countries.
This included policy makers, researchers in multiple ﬁelds, representatives of
civil society, and representatives of national and international institutions. The
group met three times, and multiple working papers were prepared to form the
basis for the ﬁnal report, entitled Shared Responsibilities for Health: A Coherent
Global Framework for Health Financing (Røttingen et al., 2014), which was
launched during the World Health Assembly in 2014.
The report characterises key economic, epidemiological and institutional tran-
sitions and describe how these come with both challenges and opportunities for
health ﬁnancing. Against that background, a set of policy responses is offered,
encapsulated in 20 recommendations for making progress towards a coherent
global framework for health ﬁnancing. These recommendations pertain to
domestic ﬁnancing of health systems, joint ﬁnancing of global public goods for
health, external ﬁnancing of health systems and the cross-cutting issues
of accountability and agreement on a new framework.
This issue
This special issue addresses all these questions and does so more broadly andmore
in depth than the Working Group’s Report could do. Health Economics, Policy
and Law serves as an ideal platform for such a wide-ranging health policy issue,
where economics, politics and legal considerations need to converge. While most
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contributions are in the form of academic articles, the close link to practical policy
has been sought maintained throughout. The link between the analyses and policy
making is further underscored in two editorials by leading decision makers – one
domestic and one global. Sujatha Rao, former Secretary of Health and Family
Welfare in India, comments on the past, present and future of health ﬁnancing in
India, including the interactions with external actors. Correspondingly, Mark
Dybul, the CEO of the Global Fund to Fight AIDS, Tuberculosis and Malaria,
comments on the challenges and opportunities for global health ﬁnancing as seen
from the Fund. Following this, Joe Dieleman and Annie Haakenstad highlight in
their editorial a critical issue for all areas of health ﬁnancing. They argue that a
data revolution is needed and recommend focussing on data on expenditures
across health focus area, type of care, payer and subnational units.
While this issue covers a wide range of the major topics in health ﬁnancing,
some topics are treated in less depth than others. For example, the articles do not
go thoroughly into private ﬁnancing for health, the effectiveness and cost-
effectiveness of different targets and forms of spending, priority setting across
speciﬁc services, or strategies to reduce waste. These too are all important topics
for the future of health ﬁnancing.
Domestic ﬁnancing
National within-country ﬁnancing for health in low- andmiddle-income countries
is examined in the ﬁrst four articles. Domestic sources of ﬁnancing can be private,
which include private insurance and out-of-pocket payments, or public, which
include taxes and other mandatory, prepaid, pooled mechanisms organised by the
government. In the ﬁrst article, Diane McIntyre, Filip Meheus and John-Arne
Røttingen explore potential targets for government spending on health in the
pursuit of universal health coverage. They propose two complementary targets –
government health expenditure of >5% of Gross domestic product (GDP) and
government health expenditure per capita of >$86 – offer rationales for these
levels, and argue for the usefulness of these targets in policy making.
A large majority of low- and middle-income countries currently fall short of one
or both of these targets. In the second article, Riku Elovainio and David Evans
examine the potential for raising more domestic money for health in many of these
and other countries. They ﬁnd that economic growth alone will be insufﬁcient to
ensure access to even basic health services in most of the countries studied. They
lay out a range of complementary options to increase domestic funds for health,
but conclude that universal health coverage will not be reached without also
increasing external ﬁnancing in many of the least developed countries.
Diane McIntyre and Filip Meheus look further into government revenue
generation in the third article and show that the level of revenue is not
predetermined by the country’s level of economic development. Instead, it is
very much a question of ﬁscal policy and political choice. They describe
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how governments can increase revenue through both tax-related and other stra-
tegies, and they offer arguments for choosing the most progressive strategies
available.
The complex relationship between tax and health is followed up by David
McCoy, Simukai Chigudu and Taavi Tillmann, who see this as a neglected area of
concern. In the fourth article, they describe how taxes can help address pressing
global health priorities not only through revenue generation, but also through
four other ‘Rs’: representation, redistribution, re-pricing and regulation. They
argue that the global community, including high-income countries, have a
responsibility to help realise this potential by help curbing tax avoidance and
evasion and by promoting an enabling environment for taxation more generally.
Global public goods
A conducive environment for domestic resource mobilisation can be seen as a
global public good, i.e., a good that is non-excludable (once it is provided, no
country can be prevented from enjoying it) and non-rival (one country’s enjoy-
ment of the good cannot impinge on the consumption opportunities of other
countries). The provision and ﬁnancing of such goods is itself a key area of global
health ﬁnancing, as discussed by Suerie Moon, John-Arne Røttingen and Julio
Frenk in the ﬁfth article. They consider a broad range of global public goods –
including standards and guidelines, research on the causes and treatment of
disease, and comparative evidence and analysis – and argue that institutions to
provide global public goods for health are in particular short supply. They suggest
to strengthen the ﬁnancing and provision of these goods through better data on
today’s ﬁnancing, through robust processes for prioritising among global public
goods and estimating resource needs, and through channelling more funds
through institutions ﬁt for purpose. Looking into the future, they suggest that that
some development assistance for health (DAH) might need to shift away from
ﬁnancing health programmes in recipient countries towards ﬁnancing global
public goods for health.
External ﬁnancing
Such a shift does not imply, however, that traditional DAHwill become irrelevant
in the near future. This kind of ﬁnancing comprises grants and concessional loans
from one country to another. With the new, ambitious Sustainable Development
Goals, the need for DAH may increase rather than decrease especially for low-
income countries. Whatever the exact funding needs are, it is clear that the land-
scape for DAH has changed radically over the least two decades. In the sixth
article, Suerie Moon and Oluwatosin Omole describe several important transi-
tions and provide, against that background, a systematic overview of problems
with the current system for DAH and related proposals for change. Top challenges
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pertain to the total level of funds; volatility and uncertainty; additionality; the
share of DAH actually reaching recipient countries; priority setting; coordination;
accountability; and the rationale for DAH.
The challenge of priority setting is particularly complex and an issue where
values and evidence are highly intertwined. In the seventh article, TrygveOttersen,
Aparna Kamath, Suerie Moon, Lene Martinsen and John-Arne Røttingen review
and discuss the allocation criteria currently used by 14 major funders of DAH.
These criteria guide which countries are eligible for assistance and howmuch each
country will be offered. The authors found that several funders had only limited
information about concrete criteria publicly available, that many did not have
different criteria for DAH and other forms of development assistance, and that no
funder had criteria directly related to inequality. They also found that national
income per capita was emphasised by many funders, but that the associated
thresholds varied considerably.
These ﬁndings suggest that stakeholders should critically examine the allocation
criteria they use or otherwise support. In the eighth article, Trygve Ottersen,
Suerie Moon and John-Arne Røttingen seek to inform such an inquiry by pre-
senting a simulation of the distributional implications of 11 criteria. Speciﬁcally,
they examined for each criterion how the current global envelope of DAH would
be allocated across countries and country categories, and they found profound
variation among the criteria. For example, the group of low-income countries
received most DAH from needs-based criteria linked to domestic capacity,
while the group of upper-middle-income countries was most favoured by an
income-inequality criterion.
This speaks to one of the great challenges to the entire system of DAH: to ﬁnd
the proper role of middle-income countries in this system. In the ninth article,
Trygve Ottersen, Suerie Moon and John-Arne Røttingen address this challenge
head on. They discuss the trade-off between concerns for a country’s capacity to
meet domestic needs and the magnitude of unmet health needs in the country.
Against this background, they illustrate a capacity-based approach to setting the
level of an eligibility threshold and outline options for the future role of MICs.
Bringing it all together
The issues examined in the nine articles are all brought together in the ﬁnal article.
It presents the 20 recommendations offered by the Chatham House Working
Group. These recommendations make concrete a vision of shared responsibilities
for health ﬁnancing and link these responsibilities to quantiﬁable targets. With
regard to domestic ﬁnancing of health systems, the Working Group asserted that
every government should meet its primary responsibility for securing the health of
its own people, should commit to spend at least 5% of GDP on health and move
progressively towards this target, should ensure government health expenditures
per capita of at least $86 whenever possible, and should commit to out-of-pocket
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payments representing <20% of total health expenditures. With regard to global
public goods, the Working Group asserted that every government should meet its
key responsibility for the co-ﬁnancing of global public goods for health and that
the public funding for research and development for new technologies that spe-
ciﬁcally meet the needs of the poor should be at least doubled compared with the
current level. Finally, regarding external ﬁnancing of health systems, the Working
Group asserted that every country with sufﬁcient capacity should contribute with
such ﬁnancing and that high-income countries should commit to a contribution of
at least 0.15%of GDP, while most upper-middle-income countries should commit
to progress towards the same contribution rate. Together with the recommenda-
tions for promoting accountability and agreement, this is offered as the basis for
achieving a coherent global framework for health ﬁnancing.
The ﬁnal article further discusses the Working Group’s recommendations in
light of key events over the last two years. The authors conclude that recent events
have underscored the Group’s recommendations and the need to revise the today’s
approach to health ﬁnancing, but that these developments have also come with
new opportunities to make real progress.
We hope this issue can help stakeholders exploit these opportunities. We hope the
comprehensive assessment of the current state of global health ﬁnancing provides a
useful basis for stakeholders to explore new approaches.We hope that other analysts
and researchers will debate and critique thework, and extend the debate through new
empirical work and theoretical analyses. We hope the concrete policy recommenda-
tions provide direction for anyone who agrees that the status quo is not an option.
Most importantly, we hope this can help actors converge on a more coherent global
framework.
Acknowledgements
The editors are grateful to the members of the Working Group on Health
Financing at Chatham House Centre on Global Health Security for their
contributions to the work on which this special issue is based. The editors also
thank all the external reviewers, and Joseph Dieleman in particular, for their
comments on the articles in this issue.
References
Commission on Macroeconomics and Health. (2001), ‘Macroeconomics and health: investing
in health for economic development’, World Health Organization, Geneva.
Jamison, D. T., L. H. Summers, G. Alleyne, K. J. Arrow, S. Berkley, et al. (2013), ‘Global health
2035: a world converging within a generation’, Lancet, 382: 1898–1955.
Murray, C. J., R.M. Barber, K. J. Foreman, A. A. Ozgoren, F. Abd-Allah, et al. (2015), ‘Global,
regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries
110 T R Y G V E O T T E R S E N E T A L.
available at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1744133116000372
Downloaded from https:/www.cambridge.org/core. London School of Economics Lib, on 03 Apr 2017 at 13:20:17, subject to the Cambridge Core terms of use,
and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the
epidemiological transition’, Lancet, 386: 2145–2191.
Røttingen, J. -A., T. Ottersen, A. Ablo, D. Arhin-Tenkorang, C. Benn, et al. (2014), Shared
Responsibilities for Health: A Coherent Global Framework for Health Financing,
London: Chatham House.
Taskforce on Innovative International Financing for Health Systems (2009), ‘More money for
health, and more health for the money’, http://www.internationalhealthpartnership.net/
ﬁleadmin/uploads/ihp/Documents/Results___Evidence/HAE__results___lessons/Taskforce_
report_EN.2009.pdf [28 June 2015].
World Bank (1993), Investing in Health, Oxford: Oxford University Press.
World Health Organization (2010), Health Systems Financing: The Path to Universal
Coverage, Geneva: World Health Organization.
World Health Organization, World Bank (2015), Tracking Universal Health Coverage:
First Global Monitoring Report, Geneva: World Health Organization.
Global health ﬁnancing towards 2030 and beyond 111
available at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1744133116000372
Downloaded from https:/www.cambridge.org/core. London School of Economics Lib, on 03 Apr 2017 at 13:20:17, subject to the Cambridge Core terms of use,
